THE UNIVERSITY OF BRITISH COLUMBIA

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine
Respiratory Evaluation Sciences Program

Research Specific Projects

EVALUATION PLATFORM IN COPD (EPIC)

ABOUT:

EPIC is a comprehensive decision-analytic simulation model for chronic obstructive pulmonary disease (COPD) that incorporates population demographics, risk factors (e.g. smoking), lung function, symptoms, and disease progression. EPIC is a Discrete Event Simulation (DES) model following individuals from birth to death (as well as immigration/emigration). As individuals progress through the model, their simulated quality of life, costs, and epidemiologic measures of lung diseases will be collected. The model can be used as a generic, standardized, and validated paradigm to project the burden of respiratory diseases in the future and to estimate the cost, effectiveness, and budget impact of competing health technologies.

Video

The EPIC model looks at how policy decisions could minimize the impact of Chronic Obstructive Pulmonary Disease (COPD). In 2 minutes, learn the basics of the EPIC model: The EPIC Model in 2 Minutes

Interview

Principal investigator Mohsen Sadatsafavi discusses EPIC and ideas about decision analytic modelling with Stephanie Harvard: Mohsen Sadatsafavi on the EPIC Model

epicR: The R Package for EPIC

EPIC is an open-source model, and is publicly available as an R package through GitHub.

Peer Models Network: EPIC on the Cloud

EPIC is accessible through the PRISM clould platform of the Peer Models Network. For more information, please refer to the Peer Models Network home page.

Excel Spreadsheet

A MACRO-enalbed Excel Spreadsheet for EPIC can be downloaded from the Peer Models Repository.

Citation

Please cite:

Sadatsafavi, M., Ghanbarian, S., Adibi, A., Johnson, K., Mark FitzGerald, J., Flanagan, W., … Sin, D. (2019). Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada. Medical Decision Making. https://doi.org/10.1177/0272989X18824098

PARTNERS:

PUBLICATIONS:

RELATED IPRESS WEBAPP:

See more

See more

See more

See more

RELATED SOFTWARE:

See more

See more

See more

MORE RESEARCH

Specific Project
IMPLEMENTING PREDICTIVE ANALYTICS TOWARDS EFFICIENT COPD TREATMENTS (IMPACT)

IMplementing Predictive Analytics towards efficient COPD Treatments (IMPACT) is a CIHR-funded (Team Grant) project aimed at developing cutting-edge Precision Medicine tools for COPD, implementing them into Electronic Health Record systems, and evaluating their impact on quaity of care and outcomes in COPD.

See 7 publications

Specific Project
NOVEL OBSERVATIONAL LONGITUDINAL STUDY (NOVELTY)

NOVELTY is a prospective cohort study conducted from 2016-2021, with data from 11,243 patients across 18 countries. Individuals with a diagnosis, or suspected diagnosis, of asthma and/or COPD (including 1652 patients with severe asthma) were included in the study. NOVELTY contains a rich set of socio-demographic, clinical, and anthropometric patient data, including spirometry measurements, medication utilization, basic sociodemographic information, and health services use.

See 1 publication

Specific Project
ACUTE COPD EXACERBATION PREDICTION TOOL (ACCEPT)

The Acute COPD Exacerbation Prediction Tool (ACCEPT) is a validated clinical prediction model that predicts rate and severity of COPD exacerbations.

See 4 publications

Specific Project
PRISM: PROGRAMMABLE INTERFACE FOR STATISTICAL & SIMULATION MODELS

PRISM is a platform that makes decision-analytics and clinical prediction models accessible on the cloud. PRISM enables end-users to intract with the model they are interested in, without worrying about having the required hardware resources, or setting up complex code on their computer.

See 3 publications

Specific Project
EHEALTH TOOLS FOR PRECISION MEDICINE IN COPD

This CIHR-funded project aims at devloping and validating prediction tools for precision disease management for COPD, and implementing such tools as Web Apps to be freely accessible to the patient and care provider community.

See 6 publications

Specific Project
NATURAL HISTORY AND PATTERNS OF MEDICATION USE IN ASTHMA

This project, sponsored by an arm's length reserch contract with AstraZeneca Canada, harnesses population-based administrative health databases of British Columbia to update our esitmates of the recent trends in medication use in asthma. The emphasis of this project is on the use of short-acting beta agonists and systemic corticosteroids and how their pattern of use is evolving in patients with asthma.

See 7 publications

Specific Project
PRECISION HEALTH IN CHILDHOOD AND ADULT ASTHMA

This is an exciting multidiciplinary project on Precision Health in children and adult asthma. This project has spon off from our lab's involvement in a major Genome Canada grant (PI: [Dr. Stuart Turvey](https://bcchr.ca/our-research/researchers/results/Details/stuart-turvey)). We plan to develop Whole Disease Policy models for childhood and adult lung health and provide rigorous decision-theoretic lens to biomarker discovery activities that target lung health in children and adults.

See 3 publications

Specific Project
ECONOMIC BURDEN OF ASTHMA (EBA)

EBA was a one-year, prospective study of a population-based random sample of 622 patients with asthma in British Columbia, with the main objective of estimating the burden of asthma in terms of its direct costs, indirect costs, and quality of life.

See 12 publications

SEE ALSO

THEME

Describes the main theme used (Asthma, COPD, methodological research).

See more

METHODOLOGY

See more

About UBC

UBC Campuses

UBC Sites

Emergency Procedures   |   Terms of Use   |   UBC Copyright   |   Accessibility